Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT04287049
PHASE2
A Study of Standard Drugs for Mycobacterium Avium Complex
Sponsor: Johns Hopkins University
View on ClinicalTrials.gov
Summary
To assess the early bactericidal activity of Azithromycin 250mg by mouth daily over the first 14 days of treatment for Mycobacterium avium complex (MAC) lung disease.
Official title: Early Bactericidal Activity of Standard Drugs Used to Treat Mycobacterium Avium Complex: a Pilot Study
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2020-02-24
Completion Date
2025-03-21
Last Updated
2026-06-22
Healthy Volunteers
No
Conditions
Interventions
DRUG
Azithromycin
Azithromycin 250 mg PO daily
Locations (1)
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States